GarcÃa-Quintanilla, L.; Almuiña-Varela, P.; RodrÃguez-Cid, M.J.; Gil-Martinez, M.; Abraldes, M.J.; Gomez-Ulla, F.; González-Barcia, M.; Castro-Fernández, D.C.; Cañizo-Outeiriño, A.; Cuartero-MartÃnez, A.;
et al. Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration. Pharmaceuticals 2026, 19, 955.
https://doi.org/10.3390/ph19060955
AMA Style
GarcÃa-Quintanilla L, Almuiña-Varela P, RodrÃguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gomez-Ulla F, González-Barcia M, Castro-Fernández DC, Cañizo-Outeiriño A, Cuartero-MartÃnez A,
et al. Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration. Pharmaceuticals. 2026; 19(6):955.
https://doi.org/10.3390/ph19060955
Chicago/Turabian Style
GarcÃa-Quintanilla, Laura, Pablo Almuiña-Varela, MarÃa José RodrÃguez-Cid, MarÃa Gil-Martinez, Maximino J. Abraldes, Francisco Gomez-Ulla, Miguel González-Barcia, Diana Carolina Castro-Fernández, Antonio Cañizo-Outeiriño, Andrea Cuartero-MartÃnez,
and et al. 2026. "Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration" Pharmaceuticals 19, no. 6: 955.
https://doi.org/10.3390/ph19060955
APA Style
GarcÃa-Quintanilla, L., Almuiña-Varela, P., RodrÃguez-Cid, M. J., Gil-Martinez, M., Abraldes, M. J., Gomez-Ulla, F., González-Barcia, M., Castro-Fernández, D. C., Cañizo-Outeiriño, A., Cuartero-MartÃnez, A., Estany-Gestal, A., Otero-Espinar, F. J., Fernández-RodrÃguez, M., & Fernández-Ferreiro, A.
(2026). Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration. Pharmaceuticals, 19(6), 955.
https://doi.org/10.3390/ph19060955
